ALOX5, a key rate-limiting enzyme in AA metabolism, is responsible for catalyzing the conversion of 5-hydroperoxyeicosatetraenoic acid to LTA4, thus contributing to the occurrence and progression of inflammation and degenerative diseases [45]. Here, ALOX5 is linked to neurodegenerative disease.